Photochemical Inactivation of Hepatitis E Virus (HEV) in Platelet Samples (PCs) using Mirasol Pathogen Reduction Technology (PRT) system

被引：0
|
作者：
Owada, T. [1 ]
Kaneko, M. [1 ]
Matsumoto, C. [1 ]
Igarashi, M. [1 ]
Uchida, S. [1 ]
Satake, M. [1 ]
Tadokoro, K. [1 ]
机构：
[1] Japanese Red Cross Soc, Cent Blood Inst, Tokyo, Japan
来源：
TRANSFUSION | 2013年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：215A / 215A
页数：1
相关论文
共 31 条
  • [1] Photochemical inactivation of Chikungunya virus using the Mirasol® pathogen reduction technology (PRT) system
    Keil, S.
    Vanlandingham, D.
    Tsetsarkin, K.
    Goodrich, R.
    Higgs, S.
    [J]. TRANSFUSION, 2008, 48 (02) : 89A - 89A
  • [2] PHOTOCHEMICAL INACTIVATION OF USUTU VIRUS USING THE MIRASOL PATHOGEN REDUCTION TECHNOLOGY (PRT) SYSTEM FOR PLATELETS
    Rossini, G.
    Silenzi, S.
    Govoni, M.
    Randi, V
    Pierro, A. M.
    Gaibani, P.
    Cavrini, F.
    Landini, M. P.
    Sambri, V
    [J]. VOX SANGUINIS, 2012, 103 : 188 - 188
  • [3] PHOTOCHEMICAL INACTIVATION OF HUMAN HEPATITIS B VIRUS USING THE MIRASOL® PATHOGEN REDUCTION TECHNOLOGY (PRT) SYSTEM AS MEASURED BY PCR
    Keil, D.
    Miklauz, M. M.
    Gilmour, D., I
    Goodrich, R. P.
    [J]. VOX SANGUINIS, 2010, 99 : 257 - 257
  • [4] Photochemical Inactivation of Hepatitis C Virus (HCV) using the Mirasol® PRT System
    Bengrine, A.
    Keil, S. D.
    Marschner, S.
    Goodrich, R.
    Duverlie, G.
    [J]. TRANSFUSION, 2013, 53 : 212A - 213A
  • [5] Photochemical Inactivation of Chikungunya Virus Using the Mirasol® PRT System
    Vanlandingham, D. L.
    Keil, S. D.
    Goodrich, R. P.
    Higgs, S.
    [J]. TRANSFUSION, 2010, 50 : 211A - 211A
  • [6] Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system
    Vanlandingham, Dana L.
    Keil, Shawn D.
    Horne, Kate McElroy
    Pyles, Richard
    Goodrich, Raymond P.
    Higgs, Stephen
    [J]. TRANSFUSION, 2013, 53 (02) : 284 - 290
  • [7] Photochemical Inactivation of La Crosse Virus (LCV) using the Mirasol® PRT System
    Keil, S. D.
    Marschner, S.
    Gosney, E. J.
    Bowen, R.
    [J]. TRANSFUSION, 2013, 53 : 217A - 217A
  • [8] Neutrophil Priming Activity in Platelet Concentrates (PCs) Collected by Apheresis and Treated with Mirasol® Pathogen Reduction Technology (PRT)
    Ambruso, D. R.
    Thurman, G.
    Tran, K.
    Marschner, S.
    Goodrich, R. P.
    [J]. TRANSFUSION, 2009, 49 : 9A - 9A
  • [9] Molecular and cell biological evaluations of human WBC inactivation using Mirasol® pathogen reduction technology (PRT)
    Li, J
    McLean, R
    Goodrich, RP
    [J]. TRANSFUSION, 2005, 45 (03) : 29A - 29A
  • [10] Effects of a new pathogen-reduction technology (Mirasol PRT) on platelet function.
    Diaz-Ricart, M
    Perez-Pujol, S
    Tonda, R
    Lozano, M
    Fuste, B
    Lopez-Vilchez, I
    Galan, AM
    Li, JZ
    Goodrich, R
    Escolar, G
    [J]. BLOOD, 2004, 104 (11) : 988A - 988A
1234